Yesterday we looked at three ASX shares brokers have given buy ratings to this week.
Unfortunately, not all shares are in favour with brokers right now. Three that have just been given sell ratings are listed below. Here’s why these brokers are bearish on these ASX shares:
Commonwealth Bank of Australia (ASX: CBA)
According to a note out of Citi, its analysts have retained their sell rating and $90.75 price target on this banking giant’s shares. Citi has been looking at the banking sector and believes cash rate increases could support stronger than expected net interest margins in the near future. While this makes the broker bullish on a couple of the big four banks, it isn’t enough for a more positive rating on CBA. It continues to see its shares as expensive. The CBA share price is trading at $106.09 on Tuesday.
Evolution Mining Ltd (ASX: EVN)
A note out of Credit Suisse reveals that its analysts have retained their underperform rating but lifted their price target on this gold miner’s shares to $3.80. This follows a review of the resources sector which has seen the broker lift its gold price forecasts. However, while this has supported an increase in its valuation, it isn’t enough for a change of rating. The Evolution share price is fetching $4.45 this afternoon.
Pro Medicus Limited (ASX: PME)
Analysts at Goldman Sachs have retained their sell rating and $44.80 price target on this health imaging technology company’s shares. Goldman notes that Pro Medicus has signed a major $32 million eight-year deal with Inova Health System. While the broker was pleased with the deal, is a fan of the company, and is positive on its long term outlook, it believes its shares are expensive at 54x earnings. Particularly as it does not have sufficient visibility that recent win-rates can be sustained. The Pro Medicus share price is trading at $47.31 on Tuesday.
The post Leading brokers name 3 ASX shares to sell today appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of January 12th 2022
More reading
- 5 things to watch on the ASX 200 on Tuesday
- Why are ASX 200 bank shares having such a stellar start to the week?
- Here’s how CBA shares stacked up over the March quarter
- Is the NAB share price entering a ‘sweet spot’?
- How retirees can maximise returns from ASX dividend shares: fund manager
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/YwIWRsG
Leave a Reply